QualityDipStocks / Industrials · Defense & government services
Karman KRMN
Outside our quality screen, so we don’t track its dips. It’s 66% below its 52-week high.
Outside our quality screen, 10% over its Market Value. No fair value estimate for now: its free cash flow is negative.
Worth knowing
- Down 67% from its 52-week high while revenue grew 50%
- Share count down 21% in 2 years
From the data on this page, as of the last close. How we pick these
- Fair value est.
- n/a
- Market Value
- $35.49price +10%
- Off 52-wk high
- −66%
- Risk vs market
- Highbeta 2.33
5 bullish · 5 bearish See why
Repriced or dip?
Dip: business intact
The price is 66% below its 52-week high (Jan 28), but the business held up: revenue +37.7%, earnings per share +226.6%, operating margin +1.3 pts.
Some numbers held up (revenue +37.7%, earnings per share +226.6%, operating margin +1.3 pts), others slipped. The price is 66% below its 52-week high.
The price is 66% below its 52-week high, and the business changed too.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 8 numbers, high vs now
- Revenue, last 12 months$428M → $590M (+37.7%)held up
- Earnings per share, 12 months$0.09 → $0.28 (+226.6%)held up
- Operating margin15.5% → 16.8% (+1.3 pts)held up
- Shares outstanding+0.4% (more shares, each owns less)held up
- Net cash (cash minus debt)+0.6% of market cap since the highheld up
- Stock vs its sector (Industrials)stock −66%, sector median +2% since Jan 28changed
- Price fall vs business numbersprice −66%, revenue/EPS/FCF median +132% (shown, not scored)
- Valuation multipleP/E 1345.7× at the high → 139.8× now (shown, not scored)
Business numbers as reported at the high (12 months to Sep 30, 2025) vs the latest filing (12 months to Jun 30, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
52-wk high: P/E 1345.7×; 52-wk low: P/E 107.4×; now: P/E 139.8×.
| High | Low | Now | |
|---|---|---|---|
| Price | $115.29Jan 28 | $30.14Oct 14 | $39.13 |
| Implied growth | n/a | n/a | n/a |
| P/E | 1345.7× | 107.4× | 139.8× |
| EV/Sales | 35.6× | 6.7× | 8.7× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Reverse DCF: the same 10-year free-cash-flow model as our fair value estimate (9.5% discount rate, growth for years 1–5 fading to 3% by year 10, 3% after), solved for the growth that makes it equal the market value at each price. For the high and the low we use only the filings that were public on that day, so nothing from a later report leaks back. Market value = that close × diluted shares. P/E = market value / 12-month net income; Price / FCF = market value / 12-month free cash flow; EV / Sales = (market value + debt − cash) / 12-month revenue. Hidden when the share count moved over 20% (split, merger), free cash flow is negative, or the company reports in another currency.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
No estimate for KRMN: negative free cash flow. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much KRMN moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings much more than the market, and its own price swings are 5.9× the S&P 500’s.
- Beta vs S&P 500
- 2.33
- Volatility
- 75% vs 13% SPY
- Correlation SPY
- 0.40
- Correlation QQQ
- 0.32
How it ranks
Where KRMN stands vs every one of the 1,996 stocks we cover that has the number. Longer bar = better.
Top quarter on 2 of 5 measures
- Free cash flow yield−0.5% · free cash flow vs market capLowest 15%of 1,391
- Dividends + buybacks yield0% · cash paid out or used to retire shares, vs market capLowest 1%of 1,836
- Revenue growth, last 12 months+50% · vs the 12 months beforeTop 7%of 1,814
- Operating margin17% · of sales kept as operating profitTop 36%of 1,288
- Return on invested capital18% · profit per dollar of capitalTop 25%of 838
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
MV $35.49
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
GrowthSales grew 50% to $590M over the last 12 months vs the 12 months before (SEC filings).
GrowthDiluted EPS grew 62% to $0.13 in FY2025.
GrowthSales compounded 28% a year from FY2022 to FY2025.
ProfitabilityReturn on invested capital of 18%, above the 9.5% discount rate our DCF uses.
Balance sheetNet cash of $46M: cash and short-term investments exceed debt (Jun 30, 2026).
Top bearish points 5 of 5
ValuationFree cash flow is negative (−$28M over the last 12 months), so there’s no cash-flow value under the price.
ValuationP/E of 139.8× vs a 26.5× median for the 220 Industrials companies we cover.
Balance sheetOperating income covers interest only 2.0× over the last 12 months.
QualityDoesn’t pass our quality screen: no positive free cash flow; ROE under 12% and ROIC under 10%; net debt 5.4× EBITDA (limit 3×).
ValuationTrades 10.2% above its Market Value of $35.49, the average price paid since the Aug 28 filing.
All fundamentals
P/E 139.8 · FCF yield -0.5% · ROE 10%
Valuation
- P/E
- 139.8×Industrials median 26.5×
- Price / FCF
- n/anegative free cash flow
- FCF yield
- −0.5%
- EV / EBITDA
- 33.4×
- Price / sales
- 8.82×
- Price / book
- 12.35×
- Market cap
- $5.2Blisted
- Enterprise value
- $5.2B
Growth
- Revenue, 12 months
- $590M
- Sales growth, 12 months
- +50.2%vs the 12 months before
- Sales growth, 3 yrs
- +27.7%/yrfrom FY2022
- Diluted EPS, 12 months
- $0.27
- EPS growth, last FY
- +62.5%
- Net income, 12 months
- $37M
- Net income growth
- +366%12 months vs before
Profitability
- Gross margin
- 41.7%
- Operating margin
- 16.8%
- Net margin
- 6.3%
- FCF margin
- −4.7%
- Return on equity
- 10%
- Return on invested capital
- 18%
Balance sheet
- Cash & short-term inv.
- $52M
- Total debt
- $6M
- Net cash
- $46M
- Debt / equity
- 0.01×
- Interest coverage
- 2.0×operating income / interest
Cash flow & returns
- Free cash flow, 12 months
- −$28M
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +0.2%diluted shares vs a year ago
- Stock-based comp
- $1M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From Karman’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $-0.1B · Sales +58%
- Free cash flow, 12 months−$0.1B
- Free-cash-flow yield-0.5%
- Free-cash-flow margin−10%
- Gross margin42%
- Operating margin20%
- Return on invested capital8%
- Return on equity10%
- Sales growth (latest quarter vs year-ago quarter)+58%
- Net debt / EBITDA5.3×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $39.13
- 52-wk lowlowest close, 1 year$30.14−23.0%
- Market Valueavg paid since Aug 28$35.49−9.3%
- PriceMon Nov 2 close$39.13you are here
- 52-wk highhighest close, 1 year$115.29+194.6%
Momentum & 52-week range
RSI 58 · 5 days +5.8%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 5
- DateThu Nov 5, after the close
- Consensus EPS$0.16
- Year-ago EPS$0.10
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
KRMN is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Karman in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Defense & government services
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.